President Donald Trump is racking up deals to slash prescription drug costs, but the pocketbook victory may not translate into votes in November.

The string of deals builds on the Trump administration's push to link the nation's drug prices to cheaper ones abroad.

President Trump on Monday announced the next round of pricing deals with drugmakers, with nine new companies making such agreements.